Lyme Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by 
All the vital news, analysis, and commentary curated by our industry experts.
Lyme disease is a bacterial infection transmitted by a tick. Lyme disease is caused by the bacterium Borrelia burgdorferi. Symptoms include rash, fever, chills, fatigue, body aches and headache. Risk factors include age, gender and geographic locations.
The Lyme Disease – Drugs In Development research report provides a comprehensive overview on the therapeutics under development for Lyme Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Lyme Disease and features dormant and discontinued projects.
Key Targets in the Lyme Disease Pipeline Drugs Market
The key targets in the Lyme Disease pipeline drugs market are Outer Surface Protein A, 23S Ribosomal RNA, Borreliella burgdorferi Complement Regulator Acquiring Protein 1, Corticotropin Releasing Factor Receptor 2 and Fibronectin.
For more target insights, download a free report sample
Key mechanisms of action in the Lyme Disease pipeline drugs market
The key mechanisms of action in the Lyme Disease pipeline drugs market are Outer Surface Protein A inhibitor, 23S Ribosomal RNA inhibitor, Borreliella burgdorferi Complement Regulator Acquiring Protein 1 inhibitor, Corticotropin Releasing Factor Receptor 2 inhibitor and Fibronectin inhibitor.
To get more insights on key MoA, download a free report sample
Key routes of administration in the Lyme Disease pipeline drugs market
The key routes of administration in the Lyme Disease pipeline drugs market are intravenous, topical, nasal oral, parenteral, subcutaneous, and intramuscular.
To get more insights on key RoA, download a free report sample
Key Molecule Types in the Lyme Disease Pipeline Drugs Market
The different molecule types in the Lyme Disease pipeline drugs market are small molecule, Subunit Vaccine, Monoclonal Antibody, Recombinant Vector Vaccine, Fusion Protein, and Gene Therapy, and Peptide.
To get more insights on key molecule types, download a free report sample
Major companies in the Lyme Disease Pipeline Drugs Market
The major companies in the Lyme Disease pipeline drugs market are Flightpath BioSciences Inc, Abzyme Therapeutics LLC, Agile Sciences Inc, Applied Biotechnology Institute Inc, Artes Biotechnology GmbH, CyanVacLLC, Greffex Inc, and Inovio Pharmaceuticals Inc.
Lyme Disease Pipeline Drugs Market Overview
| Key routes of administration | Intravenous, Topical, Nasal Oral, Parenteral, Subcutaneous, and Intramuscular
|
| Key molecule types | Small Molecule, Subunit Vaccine, Monoclonal Antibody, Recombinant Vector Vaccine, Fusion Protein, Peptide, and Gene Therapy |
| Major companies | Flightpath BioSciences Inc, Abzyme Therapeutics LLC, Agile Sciences Inc, Applied Biotechnology Institute Inc, Artes Biotechnology GmbH, CyanVacLLC, Greffex Inc, and Inovio Pharmaceuticals Inc |
| Key targets | Outer Surface Protein A, 23S Ribosomal RNA, Borreliella burgdorferi Complement Regulator Acquiring Protein 1, Corticotropin Releasing Factor Receptor 2 and Fibronectin
|
| key mechanisms of action | Outer Surface Protein A inhibitor, 23S Ribosomal RNA inhibitor, Borreliella burgdorferi Complement Regulator Acquiring Protein 1 inhibitor, Corticotropin Releasing Factor Receptor 2 inhibitor and Fibronectin inhibitor |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Lyme Disease
- The pipeline guide reviews pipeline therapeutics for Lyme Disease by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Lyme Disease therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Lyme Disease therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for Lyme Disease
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with a potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Lyme Disease
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Lyme Disease pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.
Agile Sciences Inc
Applied Biotechnology Institute Inc
Artes Biotechnology GmbH
Cortene Inc
CyanVac LLC
Flightpath BioSciences Inc
Greffex Inc
Inovio Pharmaceuticals Inc
Ixodes AG
L2 Diagnostics LLC
NovoBiotic Pharmaceuticals LLC
Planet Biotechnology Inc
Reven Holdings Inc
Tarsus Pharmaceuticals Inc
Valneva SE
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets in the Lyme Disease drugs market?
The key targets in the Lyme Disease drugs market are Outer Surface Protein A, 23S Ribosomal RNA, Borreliella burgdorferi Complement Regulator Acquiring Protein 1, Corticotropin Releasing Factor Receptor 2 and Fibronectin.
-
What are the key mechanisms of action in the Lyme Disease pipeline drugs market?
The key mechanisms of action in the Lyme Disease pipeline drugs market are Outer Surface Protein A inhibitor, 23S Ribosomal RNA inhibitor, Borreliella burgdorferi Complement Regulator Acquiring Protein 1 inhibitor, Corticotropin Releasing Factor Receptor 2 inhibitor and Fibronectin inhibitor.
-
What are the different molecule types in the Lyme Disease pipeline drugs market?
The different molecule types in the Lyme Disease pipeline drugs market are small molecule, Subunit Vaccine, Monoclonal Antibody, Recombinant Vector Vaccine, Fusion Protein, Peptide, and Gene Therapy.
-
What are the key routes of administration in the Lyme Disease pipeline drugs market?
The key routes of administration in the Lyme Disease pipeline drugs market are intravenous, topical, nasal oral, parenteral, subcutaneous, and intramuscular,
-
What are the major companies in the Lyme Disease pipeline drugs market?
The major companies in the Lyme Disease pipeline drugs market are Flightpath BioSciences Inc, Abzyme Therapeutics LLC, Agile Sciences Inc, Applied Biotechnology Institute Inc, Artes Biotechnology GmbH, CyanVacLLC, Greffex Inc, and Inovio Pharmaceuticals Inc
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Infectious Disease reports